Third COVID-19 vaccine dose for people with multiple sclerosis who did not seroconvert following two doses of BBIBP-CorV (Sinopharm) inactivated vaccine: A pilot study on safety and immunogenicity
Sedaghat, Nahad, Etemadifar, Masoud, Lotfi, Noushin, Sayahi, Farnaz, Chitsaz, Ahmad, Salari, Mehri, Ghasemi Movaghar, Alireza
Published in Frontiers in immunology (21.02.2023)
Published in Frontiers in immunology (21.02.2023)
Get full text
Journal Article
Atherosclerosis and multiple sclerosis: An overview on the prevalence of risk factors
Etemadifar, Masoud, Salari, Mehri, Esnaashari, Ali, Ghazanfaripoor, Faeze, Sayahi, Farnaz, Akhavan Sigari, Amirhossein, Sedaghat, Nahad
Published in Multiple sclerosis and related disorders (01.02.2022)
Published in Multiple sclerosis and related disorders (01.02.2022)
Get full text
Journal Article
Ginseng in the treatment of fatigue in multiple sclerosis: a randomized, placebo-controlled, double-blind pilot study
Etemadifar, Masoud, Sayahi, Farnaz, Abtahi, Seyed-Hossein, Shemshaki, Hamidreza, Dorooshi, Gholam-Ali, Goodarzi, Mohammad, Akbari, Mojtaba, Fereidan-Esfahani, Mahboobeh
Published in International journal of neuroscience (01.07.2013)
Published in International journal of neuroscience (01.07.2013)
Get full text
Journal Article
Early-Onset Multiple Sclerosis in Isfahan, Iran: Report of the Demographic and Clinical Features of 221 Patients
Etemadifar, Masoud, Nourian, Sayed-Mohammadamin, Nourian, Niloofaralsadat, Abtahi, Seyed-Hossein, Sayahi, Farnaz, Saraf, Zahra, Fereidan-Esfahani, Mahboobeh
Published in Journal of child neurology (01.06.2016)
Published in Journal of child neurology (01.06.2016)
Get more information
Journal Article